The FDA announced today that it has approved the first generic naloxone hydrochloride nasal spray, a life-saving medication that is designed to stop or reverse opioid overdose effects.
The FDA also said that it is planning new steps to prioritize the review of other generic drug applications that treat opioid overdose.
Nearly 400,000 people have died from an opioid overdose between 1999 and 2017, according to the Centers for Disease Control and Prevention. Approximately 130 Americans die every day from overdoses that involve opioids, including prescription medication and street drugs like heroin, which is often laced with fentanyl. Once an overdose occurs, reviving a person to full consciousness can be difficult. Breathing slows down and can even stop, which in turn can lead to death.
Get the full story on our sister site, Drug Delivery Business.
